Central Florida Kidney Specialists

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• IgA nephropathy4 trials

Phase

• Phase 32 trials
• Phase 21 trial
• Phase 41 trial

Status

• Active, not recruiting2 trials
• Recruiting2 trials

Lead sponsor

• Asahi Kasei Therapeutics, AB1 trial
• Biogen1 trial
• Hoffmann-La Roche1 trial
• Novartis Pharmaceuticals1 trial

Running trials

• Recruiting

  A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)

  NCT06935357· Phase 3· Biogen· Source

  Contact: Arvind Madan (principal investigator)

• Recruiting

  Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN

  NCT06797518· Phase 2· Novartis Pharmaceuticals· Source

  Contact: Felipe Gomez

• Active, not recruiting

  Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy

  NCT06712407· Phase 4· Asahi Kasei Therapeutics, AB· Source

• Active, not recruiting

  A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression

  NCT05797610· Phase 3· Hoffmann-La Roche· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• IgA nephropathy2 recruiting